2015
DOI: 10.1590/1981-38212014000200010
|View full text |Cite
|
Sign up to set email alerts
|

Biopiracy after the Nagoya Protocol: Problem Structure, Regime Design and Implementation Challenges

Abstract: As a result, in light of both problem structure and regime design, the Protocol only offers modest improvements over the status quo ante.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 19 publications
0
12
0
1
Order By: Relevance
“…The Convention on Biological Diversity (CBD) was the first international agreement to regulate access to and research on genetic resources and biotechnology and resulting benefit sharing (Rubin & Fish 1994). The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization (henceforth: Nagoya Protocol) from 2014 implements the objectives of the CBD, focusing specifically on access to genetic resources, biotechnology, and associated traditional knowledge (Young 2013;Oberthür & Rosendal 2013;Rabitz 2015). It is often misunderstood that the Nagoya Protocol implies new national regulations that did not previously exist, when in fact most parties to the protocol had such regulations in place even long before the CBD, and the Nagoya Protocol is only an instrument to implement international control on these regulations as agreed upon in the CBD more than twenty years prior.…”
Section: The Nagoya Protocol: Improvement or Impediment To The Sciencmentioning
confidence: 99%
See 1 more Smart Citation
“…The Convention on Biological Diversity (CBD) was the first international agreement to regulate access to and research on genetic resources and biotechnology and resulting benefit sharing (Rubin & Fish 1994). The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization (henceforth: Nagoya Protocol) from 2014 implements the objectives of the CBD, focusing specifically on access to genetic resources, biotechnology, and associated traditional knowledge (Young 2013;Oberthür & Rosendal 2013;Rabitz 2015). It is often misunderstood that the Nagoya Protocol implies new national regulations that did not previously exist, when in fact most parties to the protocol had such regulations in place even long before the CBD, and the Nagoya Protocol is only an instrument to implement international control on these regulations as agreed upon in the CBD more than twenty years prior.…”
Section: The Nagoya Protocol: Improvement or Impediment To The Sciencmentioning
confidence: 99%
“…Therefore, the bulk of the bureaucratic burden associated with the protocol, both for researchers and for the administrators checking these data, lies in fields of basic research that are not part of the problem actually targeted by these regulations. It has also been argued that the protocol, while putting additional burdens on noncommercial biodiversity research, does not effectively prevent biopiracy (Rabitz 2015). Further, the measure comes at a time when the pharmaceutical industry has largely shifted to synthetic, combinatorial chemistry (Beutler 2009), and results in terms of drugs derived from broad-scale biodiversity screening programs are very limited (Snader & McCloud 1994).…”
Section: Three Challenges To Contemporaneous Taxonomymentioning
confidence: 99%
“…Hence, it was in their interests to establish better compliance mechanisms. To some extent, the Protocol addressed this issue through the introduction of Articles 15–18, but it is ineffective in relation to the level of compliance as it fails to specify any measures other than a qualification that compliance must be appropriate, effective and proportionate (Rabitz, , p. 30, 38; Richerzhagen, , p. 131, 146). In practice, user states and private companies seek the largest return from their investment and therefore lack the incentive to enforce benefit‐sharing objectives (Tvedt, ).…”
Section: Has There Been a Balance Between Users And Providers?mentioning
confidence: 99%
“…O desenvolvimento territorial a partir dos RGs depende diretamente dessa boa articulação, buscando evitar as contradições tal qual a biopirataria, que é um problema particularmente ruim resultante de conflitos entre os utilizadores (privados) e países provedores, a dificuldade técnica de monitorar a utilização de RG's num contexto transnacional, e os muitos interesses internacionais. (Rabitz, 2015, tradução nossa) 115…”
unclassified
“…"That biopiracy is a particularly malignant problem resulting from distributional conflicts between (private) users and provider countries, the technical difficulty of monitoring utilization of GR in a transnational context, and the international constellation of interests." (Rabitz, 2015).…”
mentioning
confidence: 99%